These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 17219351)
1. Microcirculation as a novel marker of membrane biocompatibility. Teatini U; Ballerini L; Romei Longhena G; Savino R; Maltagliati L; Masi F; Colombo R; Cimino R; Manfredi A Int J Artif Organs; 2006 Dec; 29(12):1117-20. PubMed ID: 17219351 [TBL] [Abstract][Full Text] [Related]
2. Effect of different dialyzer membranes on cutaneous microcirculation during hemodialysis. Sato M; Morita H; Ema H; Yamaguchi S; Amano I Clin Nephrol; 2006 Dec; 66(6):426-32. PubMed ID: 17176914 [TBL] [Abstract][Full Text] [Related]
3. Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes. Sirolli V; Ballone E; Amoroso L; Di Liberato L; Di Mascio R; Capelli P; Albertazzi A; Bonomini M Int J Artif Organs; 1999 Aug; 22(8):536-42. PubMed ID: 10533909 [TBL] [Abstract][Full Text] [Related]
4. Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. Cianciolo G; Stefoni S; Donati G; De Pascalis A; Iannelli S; Manna C; Colì L; Bertuzzi V; La Manna G; Raimondi C; Boni P; Stefoni V Nephrol Dial Transplant; 2001 Jun; 16(6):1222-9. PubMed ID: 11390724 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation. Kuragano T; Kuno T; Takahashi Y; Yamamoto C; Nagura Y; Takahashi S; Kanmatsuse K Blood Purif; 2003; 21(2):176-82. PubMed ID: 12601261 [TBL] [Abstract][Full Text] [Related]
6. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane. Sirolli V; Ballone E; Di Stante S; Amoroso L; Bonomini M Int J Artif Organs; 2002 Jun; 25(6):529-37. PubMed ID: 12117292 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of oxidative and antioxidative capacity during high-flux hemodialysis using two different membranes. Schönermarck U; Dengler C; Ebeling F; Heydenreich M; Hillebrand GF; Samtleben W Clin Nephrol; 2006 Nov; 66(5):357-63. PubMed ID: 17140165 [TBL] [Abstract][Full Text] [Related]
8. Leukocytes, eosinophils and complement function during hemodialysis with polysulphone and polymethylmethacrylate membranes: comparison with cuprophan and polyacrylonitrile. Bergesio F; Monzani G; Manescalchi F; Boccabianca I; Passaleva A; Frizzi V Blood Purif; 1988; 6(1):16-26. PubMed ID: 3345242 [TBL] [Abstract][Full Text] [Related]
9. Does an alteration of dialyzer design and geometry affect biocompatibility parameters? Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675 [TBL] [Abstract][Full Text] [Related]
10. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study. Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505 [TBL] [Abstract][Full Text] [Related]
11. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers. van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491 [TBL] [Abstract][Full Text] [Related]
12. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis. Sirolli V; Di Stante S; Stuard S; Di Liberato L; Amoroso L; Cappelli P; Bonomini M Int J Artif Organs; 2000 Jun; 23(6):356-64. PubMed ID: 10919752 [TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of hemodialysis membranes: a study in healthy subjects. Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580 [TBL] [Abstract][Full Text] [Related]
14. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?]. Lovcić V; Kes P; Zeljko R; Kusec V Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832 [TBL] [Abstract][Full Text] [Related]
15. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis. de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797 [TBL] [Abstract][Full Text] [Related]
16. Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone. Amato M; Salvadori M; Bergesio F; Messeri A; Filimberti E; Morfini M Int J Artif Organs; 1988 May; 11(3):175-80. PubMed ID: 3261279 [TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104 [TBL] [Abstract][Full Text] [Related]
18. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial. Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165 [TBL] [Abstract][Full Text] [Related]
19. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation. De Sanctis LB; Stefoni S; Cianciolo G; Colì L; Buscaroli A; Feliciangeli G; Borgnino LC; Bonetti M; Gregorini MC; De Giovanni P; Buttazzi R Int J Artif Organs; 1996 Jul; 19(7):404-10. PubMed ID: 8841854 [TBL] [Abstract][Full Text] [Related]
20. Effects of dialyzer membrane on serum albumin levels in patients receiving hemodialysis. Rault RM Int J Artif Organs; 2003 Nov; 26(11):1002-4. PubMed ID: 14708829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]